GlaxoSmithKline Consumer Healthcare Limited =ANNUAL RESULTS FOR 2010, 2009,2008 COMPARED = EXCELLENT PERFORMANCE IN 2010

GlaxoSmithKline Consumer Healthcare Limited

NSE Symbol GSKCONS

GLAXO SMITHKLINE has declared excellent Results for the Year ended December 2010, compared to the previous  2 years.

Net Sales in Jan-Dec 2010 are : Rs.2306 cr – up by 20.02% Compared to Jan-dec 2009 and by 49.48% compared to 2008.

Total Expenditure in 2010 is Rs.1969 cr – up by 19.15% from 2009 and by 46.16% from 2008.

Profit from operations is Rs.405 cr – up by 22.11% from 2009 and by 65.1% from 2008.

Net profit for 2010 is Rs.300 cr – up by 28.81% from 2009 and by 59.22% from 2008.

Basic EPS on a Face Value of Rs.10 is Rs.71.3 for 2010, against Rs. 55.35 in  2009 and Rs.44.78 in 2008.

Thus, on an annual basis, Glaxo has done excellently in the year 2010 compared to the previous 2 years.

RESULTS TABLE :

GLAXO S	FY JAN-DEC 2010	JAN-DEC 2009	JAN-DEC 2008
Net Sales	230612	192150	154278
DIF %1	2306	20.02	49.48
Other Oprtng Income	6763	6255	4952
Incre./Decr.in SIT / WIP	-2980	-1720	-4605
Raw Materials	77834	66258	63180
traded goods	11637	6523	-
Employees Cost	22966	20070	17195
Depreciation	3971	4202	4195
Other Expenditure	83483	69936	54756
Total Expenditure	196911	165269	134721
DIF %2	1969	19.15	46.16
Profit from Operations	40464	33136	24509
DIF %3	405	22.11	65.1
Other Income	4976	2677	4596
Profit before I & EI	45440	35813	29105
Interest	260	427	697
Profit after Int. BB EI	45180	35386	28408
Profit( before tax	45180	35386	28408
Tax Expense	15195	12108	9575
Net Profit after tax	29985	23278	18833
Net Profit	29985	23278	18833
DIF %4	300	28.81	59.22
Face Value (in Rs.)	10	10	10
Paid-up Equity	4206	4206	4206
Basic EPS	71.3	55.35	44.78
Public Shareholding (%)	56.84	56.84	-

ANNOUNCEMENTS

TO THE EXCHANGE

02-02-2011    GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2010 as follows: Net Sales of Rs. 230612 lacs for year ending on 31-DEC-2010 against Rs. 192150 lacs for the year ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 29985 lacs for the year ending on 31-DEC-2010 against Rs. 23278 lacs for the year ending on 31-DEC-2009.   -

02-02-2011    GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 50776 lacs for quarter ending on 31-DEC-2010 against Rs. 41812 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 5337 lacs for the quarter ending on 31-DEC-2010 against Rs. 3368 lacs for the quarter ending on 31-DEC-2009.    -

02-02-2011    Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 02, 2011 has recommended a Dividend at the rate of Rs. 50 per equity share of Rs.10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company).

 *  *  *   E  N  D   *  *  *